FDA Updates GLP-1 Label with Pulmonary Aspiration Warning

The new warning affects labels for drugs made with semaglutide, liraglutide, and tirzepatide.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-updates-glp-1-label-pulmonary-aspiration-warning-2024a1000k84?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost